BioNTech SE (BNTX)

106.62 +1.08 (+1.02%) USD  |  NASDAQ  |  Feb 06, 16:00
106.76 +0.14 (+0.13%) After-Hours: 20:00
More

BioNTech SG&A Expense (TTM) : 597.23M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for BNTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
CureVac NV 68.15M
Novavax, Inc. 201.70M
Pfizer Inc. 13.79B
Sanofi 10.80B
Moderna, Inc. 1.061B